Roberto Luksch, MD

Permanent staff
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Milan, Lombardia, Italy

Presentation(s):

• Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)

  Friday, November 18, 2022
  2:12 PM – 2:22 PM